Percev LLC

Woodside, CA · Biotech

Mycosporine-like amino acids (MAAs) extracted from cyanobacteria using aptamer-based purification for UV protection in sunscreen and cosmetics

percev.co →
Grants
$1.4M
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
4
2 granted · 2 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · STTR Phase I: Probabilistic and Explainable Deep Learning for the Intuitive Predictive Maintenance of Industrial and Agricultural Equipment$256,000
Federal grantNational Science Foundation · Phase II · STTR Phase II:Scaling the Purification of Mycosporine-like Amino Acids to Replace Chemical Ultraviolet (UV) Filters and Protect Human and Environmental Health.$1,125,086
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2908Beacon Therapeutics——
2909ONCOARENDI THERAPEUTICS LLC——
2910MEDCHEM PARTNERS LLC——
2911Percev LLC——
2912Aiolos Bio——
2913GENSAIC, INC.——
2914TRUCODE GENE REPAIR, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 2 granted of 4
  • Joint Training Method For Predicting Remaining Useful Life Of Industrial Systems Using Time-series Dataapplication
  • Two-Tier Prognostic Model for Explainable Remaining Useful Life Predictionapplication
  • Monitoring And Control Systemsgranted
  • Wireless Sensor Devicegranted

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.